Indeed, it has been shown that mutant UBQLN2 impairs UPS function in vitro[88], implying that induction of UPS function can be a viable therapeutic option in ALS and ALS-FTD. The gene discussed is UBQLN2; the disease is amyotrophic lateral sclerosis.